Cargando…
DNA from fecal immunochemical test can replace stool for detection of colonic lesions using a microbiota-based model
BACKGROUND: There is a significant demand for colorectal cancer (CRC) screening methods that are noninvasive, inexpensive, and capable of accurately detecting early stage tumors. It has been shown that models based on the gut microbiota can complement the fecal occult blood test and fecal immunochem...
Autores principales: | Baxter, Nielson T., Koumpouras, Charles C., Rogers, Mary A. M., Ruffin, Mack T., Schloss, Patrick D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109736/ https://www.ncbi.nlm.nih.gov/pubmed/27842559 http://dx.doi.org/10.1186/s40168-016-0205-y |
Ejemplares similares
-
Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions
por: Baxter, Nielson T., et al.
Publicado: (2016) -
Normalization of the microbiota in patients after treatment for colonic lesions
por: Sze, Marc A., et al.
Publicado: (2017) -
Manipulation of the Gut Microbiota Reveals Role in Colon Tumorigenesis
por: Zackular, Joseph P., et al.
Publicado: (2015) -
Diagnostic Potential and Interactive Dynamics of the Colorectal Cancer Virome
por: Hannigan, Geoffrey D., et al.
Publicado: (2018) -
Fecal Short-Chain Fatty Acids Are Not Predictive of Colonic Tumor Status and Cannot Be Predicted Based on Bacterial Community Structure
por: Sze, Marc A., et al.
Publicado: (2019)